Your email has been successfully added to our mailing list.

×
0 -0.000550660792951432 0 0 0.000550660792951628 -0.000550660792951432 -0.000550660792951432 -0.00110132158590306
Stock impact report

MorphoSys gains after gaining U.S. antitrust approval for sale to Novartis [Seeking Alpha]

MorphoSys AG - American Depositary Shares (MOR) 
Company Research Source: Seeking Alpha
The HSR waiting period for the transaction expired, according to a statement earlier on Friday. The deal has now received all of its regulatory approvals after the company previously said it won approval in Germany and Austria. MorphoSys ( MOR ) and Novartis ( NVS ) continue to expect the closing of the takeover offer to take place in the first half of this year. Novartis ( NVS ) last month agreed to make a voluntary public takeover offer to acquire cancer drugmake r MorphoSys AG ( MOR for EUR 68/share. Recommended For You More Trending News Recommended For You More Trending News Related Stocks Trending Analysis Trending News Show less Read more
Impact Snapshot
Event Time:
MOR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for MOR alerts
Opt-in for
MOR alerts

from News Quantified
Opt-in for
MOR alerts

from News Quantified